Coloplast As Sp/Adr (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,575 | 127,994 | 129,438 | 132,270 | 130,637 |
| Receivables | 806,970 | 825,396 | 808,371 | 756,800 | 734,208 |
| Inventories | 533,909 | 530,447 | 518,627 | 508,144 | 505,055 |
| TOTAL | $1,518,558 | $1,535,352 | $1,512,930 | $1,453,964 | $1,424,966 |
| Non-Current Assets | |||||
| PPE Net | 821,365 | 792,929 | 778,378 | 756,078 | 735,785 |
| Investments And Advances | 10,760 | 11,111 | 11,211 | 9,386 | 9,321 |
| Intangibles | 4,410,273 | 4,411,684 | 4,426,677 | 4,539,936 | 4,481,967 |
| Other Non-Current Assets | 228,859 | 259,018 | 279,988 | 257,177 | 253,962 |
| TOTAL | $5,471,256 | $5,474,742 | $5,496,254 | $5,562,577 | $5,481,035 |
| Total Assets | $6,989,814 | $7,010,094 | $7,009,184 | $7,016,541 | $6,906,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,004,328 | 706,014 | 699,618 | 695,060 |
| Accounts payable and accrued liabilities | 573,458 | 530,158 | 539,448 | 686,911 | 651,466 |
| Other current liabilities | 747,501 | 14,286 | 1,043,661 | 643,880 | 353,051 |
| TOTAL | $1,483,662 | $1,798,699 | $2,519,608 | $2,731,759 | $2,338,997 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,407,388 | 2,389,608 | 1,683,427 | 1,668,253 | 1,657,417 |
| Other Non-Current Liabilities | 489,998 | 437,373 | 447,429 | 432,478 | 428,910 |
| TOTAL | $2,897,386 | $2,826,981 | $2,130,856 | $2,100,731 | $2,086,327 |
| Total Liabilities | $4,381,047 | $4,625,681 | $4,650,464 | $4,832,490 | $4,425,324 |
| Shareholders' Equity | |||||
| Common Shares | 33,151 | 32,900 | 33,197 | 32,923 | 32,695 |
| Retained earnings | 2,237,851 | 2,542,566 | 2,376,774 | 2,301,014 | 2,098,229 |
| Other shareholders' equity | 337,765 | -191,053 | -51,251 | -149,887 | 349,753 |
| TOTAL | $2,608,767 | $2,384,413 | $2,358,720 | $2,184,050 | $2,480,677 |
| Total Liabilities And Equity | $6,989,814 | $7,010,094 | $7,009,184 | $7,016,540 | $6,906,001 |